21 – 30 of 218
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Contribution of rare genetic variants to heart failure and cardiomyopathy in the UK Biobank
(
- Contribution to journal › Letter
-
Mark
A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism
(
- Contribution to journal › Article
-
Mark
Multimorbidity can run in families - What are implications for clinical practice?
2023) In BMJ(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Rare-variant collapsing analyses reveal novel risk genes for arterial and venous cardiovascular diseases in the UK biobank
(
- Contribution to journal › Letter
-
Mark
“C1-inhibitor levels and Venous Thromboembolism : Results from a Mendelian Randomization Study”: comment from Grover et al
(
- Contribution to journal › Letter
- 2022
-
Mark
Thrombomodulin (THBD) gene variants and thrombotic risk in a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle-aged and older adults: A population-based cohort study
(
- Contribution to journal › Letter
-
Mark
Thrombotic risk determined by rare and common SERPINA1 variants in a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Air pollution and biomarkers of cardiovascular disease and inflammation in the Malmö Diet and Cancer cohort
(
- Contribution to journal › Article
-
Mark
Classic Thrombophilias and Thrombotic Risk Among Middle-Aged and Older Adults : A Population-Based Cohort Study
(
- Contribution to journal › Article